BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 25121365)

  • 1. Association of polymorphisms of CYP2C9, CYP2C19, and ABCB1, and activity of P-glycoprotein with response to anti-epileptic drugs.
    Taur SR; Kulkarni NB; Gandhe PP; Thelma BK; Ravat SH; Gogtay NJ; Thatte UM
    J Postgrad Med; 2014; 60(3):265-9. PubMed ID: 25121365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABCB1 polymorphisms influence the response to antiepileptic drugs in Japanese epilepsy patients.
    Seo T; Ishitsu T; Ueda N; Nakada N; Yurube K; Ueda K; Nakagawa K
    Pharmacogenomics; 2006 Jun; 7(4):551-61. PubMed ID: 16753003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP2C9, CYP2C19, ABCB1 genetic polymorphisms and phenytoin plasma concentrations in Mexican-Mestizo patients with epilepsy.
    Ortega-Vázquez A; Dorado P; Fricke-Galindo I; Jung-Cook H; Monroy-Jaramillo N; Martínez-Juárez IE; Familiar-López I; Peñas-Lledó E; LLerena A; López-López M
    Pharmacogenomics J; 2016 Jun; 16(3):286-92. PubMed ID: 26122019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABCB1 variant provides important leads for pharmacogenetics of epilepsy.
    Phani MN; Satyamoorthy K
    J Postgrad Med; 2014; 60(3):239-40. PubMed ID: 25272393
    [No Abstract]   [Full Text] [Related]  

  • 5. Genetic factors associated with drug-resistance of epilepsy: relevance of stratification by patient age and aetiology of epilepsy.
    Sánchez MB; Herranz JL; Leno C; Arteaga R; Oterino A; Valdizán EM; Nicolás JM; Adín J; Armijo JA
    Seizure; 2010 Mar; 19(2):93-101. PubMed ID: 20064729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of association between the C3435T polymorphism in the human multidrug resistance (MDR1) gene and response to antiepileptic drug treatment.
    Sills GJ; Mohanraj R; Butler E; McCrindle S; Collier L; Wilson EA; Brodie MJ
    Epilepsia; 2005 May; 46(5):643-7. PubMed ID: 15857428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of ABCB1 C3435T polymorphism with phenobarbital resistance in Thai patients with epilepsy.
    Keangpraphun T; Towanabut S; Chinvarun Y; Kijsanayotin P
    J Clin Pharm Ther; 2015 Jun; 40(3):315-9. PubMed ID: 25846690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurological toxicity after phenytoin infusion in a pediatric patient with epilepsy: influence of CYP2C9, CYP2C19 and ABCB1 genetic polymorphisms.
    Dorado P; López-Torres E; Peñas-Lledó EM; Martínez-Antón J; Llerena A
    Pharmacogenomics J; 2013 Aug; 13(4):359-61. PubMed ID: 22641027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of genetic variants of CYP2D6, CYP2C9, CYP2C19 and CYP3A4 on antiepileptic drug metabolism in pediatric patients with refractory epilepsy.
    López-García MA; Feria-Romero IA; Serrano H; Rayo-Mares D; Fagiolino P; Vázquez M; Escamilla-Núñez C; Grijalva I; Escalante-Santiago D; Orozco-Suarez S
    Pharmacol Rep; 2017 Jun; 69(3):504-511. PubMed ID: 28343093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No association of ABCB1 polymorphisms with drug-refractory epilepsy in a north Indian population.
    Lakhan R; Misra UK; Kalita J; Pradhan S; Gogtay NJ; Singh MK; Mittal B
    Epilepsy Behav; 2009 Jan; 14(1):78-82. PubMed ID: 18812236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ABCB1 C3435T polymorphism and the risk of resistance to antiepileptic drugs in epilepsy: a systematic review and meta-analysis.
    Haerian BS; Roslan H; Raymond AA; Tan CT; Lim KS; Zulkifli SZ; Mohamed EH; Tan HJ; Mohamed Z
    Seizure; 2010 Jul; 19(6):339-46. PubMed ID: 20605481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-response to antiepileptic pharmacotherapy is associated with the ABCC2 -24C>T polymorphism in young and adult patients with epilepsy.
    Ufer M; Mosyagin I; Muhle H; Jacobsen T; Haenisch S; Häsler R; Faltraco F; Remmler C; von Spiczak S; Kroemer HK; Runge U; Boor R; Stephani U; Cascorbi I
    Pharmacogenet Genomics; 2009 May; 19(5):353-62. PubMed ID: 19415824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association analysis of intractable epilepsy with C3435T and G2677T/A ABCB1 gene polymorphisms in Iranian patients.
    Sayyah M; Kamgarpour F; Maleki M; Karimipoor M; Gharagozli K; Shamshiri AR
    Epileptic Disord; 2011 Jun; 13(2):155-65. PubMed ID: 21636342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical impact of pharmacogenetics on the treatment of epilepsy.
    Löscher W; Klotz U; Zimprich F; Schmidt D
    Epilepsia; 2009 Jan; 50(1):1-23. PubMed ID: 18627414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical relevance of genetic polymorphism in CYP2C9 gene to pharmacodynamics and pharmacokinetics of phenytoin in epileptic patients: validatory pharmacogenomic approach to pharmacovigilance.
    Kousar S; Wafai ZA; Wani MA; Jan TR; Andrabi KI
    Int J Clin Pharmacol Ther; 2015 Jul; 53(7):504-16. PubMed ID: 25943175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of a general association between ABCB1 genetic variants and response to antiepileptic drugs in epilepsy patients.
    Grover S; Bala K; Sharma S; Gourie-Devi M; Baghel R; Kaur H; Gupta M; Talwar P; Kukreti R
    Biochimie; 2010 Sep; 92(9):1207-12. PubMed ID: 20417680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CYP2C9, CYP2C19, ABCB1 (MDR1) genetic polymorphisms and phenytoin metabolism in a Black Beninese population.
    Allabi AC; Gala JL; Horsmans Y
    Pharmacogenet Genomics; 2005 Nov; 15(11):779-86. PubMed ID: 16220110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of ABCB1 genetic variants 3435C>T and 2677G>T to ABCB1 mRNA and protein expression in brain tissue from refractory epilepsy patients.
    Mosyagin I; Runge U; Schroeder HW; Dazert E; Vogelgesang S; Siegmund W; Warzok RW; Cascorbi I
    Epilepsia; 2008 Sep; 49(9):1555-61. PubMed ID: 18494787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between CYP2C9/2C19 polymorphisms and phenytoin maintenance doses in Asian epileptic patients: A systematic review and meta-analysis
.
    Liao K; Liu Y; Ai CZ; Yu X; Li W
    Int J Clin Pharmacol Ther; 2018 Jul; 56(7):337-346. PubMed ID: 29628024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Polymorphism of Drug-Metabolizing Enzymes CYP2C9 and CYP2C19 in Moroccan Population.
    Afilal D; Basselam MA; Brakez Z; Chouham S; Brehm A; Izaabel EH
    Genet Test Mol Biomarkers; 2017 May; 21(5):298-304. PubMed ID: 28282224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.